미국의 망막 아틀라스(2023년) : MedOp Index 분석
2023 United States Retina Atlas Featuring the Market Scope Exclusive MedOp Index Analysis
이 보고서는 미국의 망막 아틀라스를 조사하여 미국 85개 도시 지역의 망막 치료 기회와 주요 인구통계학적 지표에 대한 지역별 분석을 제공합니다.
The "2023 United States Retina Atlas" is now delivered exclusively in an Excel format that allows users to quickly sort through key metrics for eight United States regions, all 50 states, and the top 85 metropolitan areas in retinal treatment opportunity.
The "2023 United States Retina Atlas" provides a geographic analysis of retinal treatment opportunity and key demographic metrics in 85 US metropolitan areas. Market Scope's proprietary MedOp Index™ Analysis examines market potential and provides a benchmark against other metros. The Retina Atlas offers strategic insights into the top potential markets in the US by providing:
The "2023 United States Retina Atlas" has been prepared using a variety of primary and secondary sources, including:
Chelseahas over 10 years of experience as an analyst in multiple medical verticals.
After receiving her MBA, Chelsea began her career at Cerner Corporation, the leading supplier of healthcare information technology solutions, where she performed many analytical roles in the Population Health organization. She also has experience in crafting and executing competitive intelligence strategy, product development, and market opportunity assessment.
Chelsea authors the global ophthalmic laser report, the global refractive report, the global cornea report, the ophthalmic deals book, the US cataract atlas,the US refractive atlas, the US glaucoma atlas, and the US dry eye atlas. She is also a contributor to Market Scope's Ophthalmic Market Perspectives monthly industry newsletter.